A genetic variant of the atrial natriuretic peptide gene is associated with left ventricular hypertrophy in a non-diabetic population - the Malmö preventive project study

BMC Medical Genetics

Volumn 14, Issue 1, 2013, Pages

  Jujić, Amra ^a,b,c   Leosdottir, Margret ^b   Östling, Gerd ^c   Gudmundsson, Petri ^a   Nilsson, Peter M ^b,c   Melander, Olle ^b,c   Magnusson, Martin ^b,c  

^a MALMÖ UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATRIAL NATRIURETIC FACTOR; GLUCOSE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; ECHOCARDIOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HEREDITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PREVALENCE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

AGED; ALLELES; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SWEDEN;

EID: 84879196356     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-14-64     Document Type: Article

References (27)

1. Inagami T. Atrial natriuretic factor as a volume regulator. J Clin Pharmacol 1994, 34:424-426. 10.1002/j.1552-4604.1994.tb04982.x, 7916352.
2. Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 2004, 50:33-50. 10.1373/clinchem.2003.024760, 14633912.
3. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998, 339:321-328. 10.1056/NEJM199807303390507, 9682046.
4. John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 1995, 267:679-681. 10.1126/science.7839143, 7839143.
5. Melo LG, Steinhelper ME, Pang SC, Tse Y, Ackermann U. Anp in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models. Physiol Genomics 2000, 3:45-58.
6. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, Maeda N. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor a. Proc Natl Acad Sci USA 1997, 94:14730-14735. 10.1073/pnas.94.26.14730, 25105, 9405681.
7. Horio T, Nishikimi T, Yoshihara F, Matsuo H, Takishita S, Kangawa K. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension 2000, 35:19-24. 10.1161/01.HYP.35.1.19, 10642269.
8. Melo LG, Veress AT, Chong CK, Pang SC, Flynn TG, Sonnenberg H. Salt-sensitive hypertension in anp knockout mice: potential role of abnormal plasma renin activity. Am J Physiol 1998, 274:R255-R261.
9. Wang TJ, Larson MG, Levy D, Benjamin EJ, Corey D, Leip EP, Vasan RS. Heritability and genetic linkage of plasma natriuretic peptide levels. Circulation 2003, 108:13-16. 10.1161/01.CIR.0000081657.83724.A7, 12821537.
10. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004, 109:594-600. 10.1161/01.CIR.0000112582.16683.EA, 14769680.
11. Magnusson M, Jujic A, Hedblad B, Engstrom G, Persson M, Struck J, Morgenthaler NG, Nilsson P, Newton-Cheh C, Wang TJ, Melander O. Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective malmo diet and cancer study. J Clin Endocrinol Metab 2012, 97:638-645. 10.1210/jc.2011-2425, 3275360, 22112816.
12. Newton-Cheh C, Larson MG, Vasan RS, Levy D, Bloch KD, Surti A, Guiducci C, Kathiresan S, Benjamin EJ, Struck J, Morgenthaler NG, Bergmann A, Blankenberg S, Kee F, Nilsson P, Yin X, Peltonen L, Vartiainen E, Salomaa V, Hirschhorn JN, Melander O, Wang TJ. Association of common variants in nppa and nppb with circulating natriuretic peptides and blood pressure. Nat Genet 2009, 41:348-353. 10.1038/ng.328, 2664511,2664511, 19219041.
13. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, Najjar SS, Zhao JH, Heath SC, Eyheramendy S, Papadakis K, Voight BF, Scott LJ, Zhang F, Farrall M, Tanaka T, Wallace C, Chambers JC, Khaw KT, Nilsson P, van der Harst P, Polidoro S, Grobbee DE, Onland-Moret NC, Bots ML, Wain LV, Elliott KS, Teumer A, Luan J, Lucas G, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009, 41:666-676. 10.1038/ng.361, 2891673, 19430483.
14. Cannone V, Boerrigter G, Cataliotti A, Costello-Boerrigter LC, Olson TM, McKie PM, Heublein DM, Lahr BD, Bailey KR, Averna M, Redfield MM, Rodeheffer RJ, Burnett JC. A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community. J Am Coll Cardiol 2011, 58:629-636. 10.1016/j.jacc.2011.05.011, 3188554, 21798427.
15. Ellis KL, Newton-Cheh C, Wang TJ, Frampton CM, Doughty RN, Whalley GA, Ellis CJ, Skelton L, Davis N, Yandle TG, Troughton RW, Richards AM, Cameron VA. Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes. J Mol Cell Cardiol 2011, 50:695-701. 10.1016/j.yjmcc.2011.01.010, 21276798.
16. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the european society of cardiology (esc) and of the european association for the study of diabetes (easd). Eur Heart J 2007, 28:88-136.
17. Shehadeh A, Regan TJ. Cardiac consequences of diabetes mellitus. Clin Cardiol 1995, 18:301-305. 10.1002/clc.4960180604, 7664503.
18. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004, 25:543-567. 10.1210/er.2003-0012, 15294881.
19. Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY, Kitzman DW, Hopkins PN, Morgan D, Rao DC, Devereux RB. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: hypertension genetic epidemiology network (hypergen) study. Circulation 2001, 103:102-107. 10.1161/01.CIR.103.1.102, 11136693.
20. Leosdottir M, Willenheimer R, Plehn J, Borgquist R, Gudmundsson P, Harris TB, Launer LJ, Bjornsdottir H, Nilsson PM, Gudnason V. Myocardial structure and function by echocardiography in relation to glucometabolic status in elderly subjects from 2 population-based cohorts: a cross-sectional study. Am Heart J 2010, 159:414-420. e414, 10.1016/j.ahj.2009.12.028, 3242727, 20211303.
21. Foppa M, Duncan BB, Rohde LE. Echocardiography-based left ventricular mass estimation. How should we define hypertrophy?. Cardiovasc Ultrasound 2005, 3:17. 10.1186/1476-7120-3-17, 1183230, 15963236.
22. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Recommendations for chamber quantification: a report from the American society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463. 10.1016/j.echo.2005.10.005, 16376782.
23. Santra S, Basu AK, Roychowdhury P, Banerjee R, Singhania P, Singh S, Datta UK. Comparison of left ventricular mass in normotensive type 2 diabetes mellitus patients with that in the nondiabetic population. J Cardiovasc Dis Res 2011, 2:50-56. 10.4103/0975-3583.78597, 3120273, 21716753.
24. Poornima IG, Parikh P, Shannon RP. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 2006, 98:596-605. 10.1161/01.RES.0000207406.94146.c2, 16543510.
25. Hirata K, Watanabe H, Beppu S, Muro T, Teragaki M, Yoshiyama M, Takeuchi K, Yoshikawa J. Pitfalls of echocardiographic measurement in tissue harmonic imaging: in vitro and in vivo study. J Am Soc Echocardiogr 2002, 15:1038-1044. 10.1067/mje.2002.121537, 12373244.
26. Helak JW, Reichek N. Quantitation of human left ventricular mass and volume by two-dimensional echocardiography: in vitro anatomic validation. Circulation 1981, 63:1398-1407. 10.1161/01.CIR.63.6.1398, 7226486.
27. Reichek N, Helak J, Plappert T, Sutton MS, Weber KT. Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results. Circulation 1983, 67:348-352. 10.1161/01.CIR.67.2.348, 6848224.